The systematic erythalamus (Stystemic Lupus Erythematosus, known as SLE) is a chronic self-immuno-immuno-disease that affects mainly women, especially those of childbearing age. For women with SLE, the issue of fertility is a complex and carefully treated topic. So, is it possible to have a child with a systematic erythalamus? The answer is yes, but it requires adequate preparation and management under the guidance of a doctor.
1. Relationship between SLE and fertility
SLE itself does not directly lead to infertility, but the activity of the disease, the medication and the complications may have an impact on fertility. For example, certain immunological diseases may affect ovarian functions, while kidney stress (e.g. lupus nephritis) may increase the risk of pregnancy. SLE patients must therefore ensure that the disease is stable before planning to become pregnant and adjust the treatment programme under the guidance of a doctor.
2. Pregnancy risk
SLE patients may be at higher risk during pregnancy, including:
– Increased activity: Changes in hormonal levels during pregnancy may induce or aggravate SLE symptoms.
– Complications of pregnancy: pre-eclampsia, premature birth, limited foetal growth, etc.
– Foetal risk: SLE patients may have antiphosphate antibodies, increasing the risk of miscarriage, stillbirth or neonatal lupus.
3. Preparation for pregnancy
In order to reduce the risk of pregnancy, SLE patients must prepare for pregnancy before planning:
– Disease control: ensuring a stable period of at least six months and reducing the risk of re-emergence during pregnancy.
– Drug adjustment: Certain drugs (e.g. aminophosphate, cyclophosphate) are banned during pregnancy and need to be replaced with safe drugs (e.g. hydroxychloride) earlier.
– Comprehensive assessment: examination of kidney function, heart function, anti-phosphate antibodies etc. to assess the feasibility of pregnancy.
4. Management during pregnancy
SLE patients need to be closely monitored during pregnancy, including:
– Regular follow-up: a maternity check every 4-6 weeks to monitor disease activity and foetal development.
– Drug management: Continued use of safe drugs (e.g., hydroxychloroquine, low-dose aspirin) to control disease and prevent complications.
– Multidisciplinary collaboration: Rheumatologists, obstetricians and neonatal doctors work together to develop management plans to ensure the safety of mothers and children.
5. Post-natal care
The post-natal period is a high-risk period for SLE patients ‘ re-emergence of disease and therefore requires continued close monitoring and care. Breastfeeding is usually safe, but doctors are consulted on the basis of drug use.
6. Psychological support
SLE patients may face greater psychological stress during pregnancy and are advised to seek psychological support, maintain a positive mindset and maintain good communication with their families and doctors.
Concluding remarks
Systematic erythalamus can have children, but they need to be adequately prepared and managed under the guidance of a doctor. SLE patients can safely welcome new life through scientific pre-pregnancy assessments, close monitoring during pregnancy and post-natal care. The key is to work closely with the medical team to ensure maternal and child health.
If you or someone around you has SLE and is planning to become pregnant, you must consult a professional doctor and develop a personalized management programme to ensure that the pregnancy process is smooth and safe.
